Form 4: American Healthcare REIT Director Marvin O'Quinn Receives Restricted Stock Grant Upon Re-election

Marvin R. O'Quinn, a director of American Healthcare REIT, Inc., was granted 3,042 shares of restricted common stock following his re-election to the board, aligning his interests with shareholders.

Summary

• Marvin R. O'Quinn, a Director of American Healthcare REIT, Inc. (AHR), was granted 3,042 shares of restricted common stock.
• The grant occurred on June 25, 2025, concurrent with his re-election to the company's board of directors.
• The shares were granted at a price of $0, indicating they are part of a compensation package.
• Following this transaction, Mr. O'Quinn beneficially owns a total of 18,062 shares of common stock.
• The granted restricted shares are subject to a vesting period and will vest on June 25, 2026.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director upon re-election, which is a standard corporate governance practice aimed at aligning interests. This is a neutral to slightly positive event as it indicates continued board stability and commitment.

Positives

• The grant of restricted stock to Director Marvin R. O'Quinn upon re-election aligns his financial interests directly with those of the shareholders, promoting long-term commitment and performance.
• The transaction reflects a standard practice of compensating board members with equity, which can incentivize sound corporate governance and strategic decision-making.

Negatives

• No negative aspects are directly discernible from this routine Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

The 3,042 shares of restricted common stock granted to Director Marvin R. O'Quinn are scheduled to vest on June 25, 2026, indicating a future milestone for this equity compensation.

Management Comments

• While no direct quotes are provided, the transaction reflects the company's compensation policy for its directors, indicating management's decision to grant equity as part of director remuneration.

Industry Context

The granting of restricted stock to directors as part of their compensation package is a common and widely accepted practice across various industries, including the healthcare REIT sector. This method aims to align the interests of the board members with the long-term performance and shareholder value of the company.

Comparison to Industry Standards

• This type of equity grant to a director upon re-election is a standard practice in corporate governance, aligning with compensation structures seen in other publicly traded REITs and companies across various sectors.
• While specific comparable companies or projects are not detailed in the filing, the mechanism of granting restricted stock for director service is a common benchmark for non-cash compensation, aiming to foster long-term commitment and shareholder alignment.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings are mentioned in this Form 4 filing.

Related Party Transactions

• The grant of restricted common stock to Marvin R. O'Quinn, a director of American Healthcare REIT, Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with shareholders, potentially fostering better long-term decision-making and value creation.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Vesting of the 3,042 restricted common stock shares on June 25, 2026.

Key Dates

Keywords

American Healthcare REIT, AHR, Marvin R. O'Quinn, SEC Form 4, director compensation, restricted stock, equity grant, corporate governance, insider transaction